ZFIN Fish: naca^t30953/t30953

ZFIN ID: ZDB-FISH-171101-4

ZFIN ID: ZDB-FISH-171101-4

Fish name:	naca^{t30953/t30953}
Genotype:	naca^{t30953/t30953}
Targeting Reagent:	none

HUMAN DISEASE MODELED by naca^{t30953/t30953}
No data available

GENE EXPRESSION
Gene expression in naca^{t30953/t30953}

RNA expression

Expressed Gene	Structure	Conditions	Figures
atf4a	whole organism	standard conditions	Fig. 8 from Murayama et al., 2015
atf6	whole organism	standard conditions	Fig. 8 from Murayama et al., 2015
cebp1	granulocyte	standard conditions	Fig. 1 from Murayama et al., 2015
csf1ra	macrophage	standard conditions	Fig. 1 from Murayama et al., 2015
ddit3	whole organism	standard conditions	Fig. 8 from Murayama et al., 2015
eif2ak3	whole organism	standard conditions	Fig. 8 from Murayama et al., 2015
ern1	whole organism	standard conditions	Fig. 8 from Murayama et al., 2015
hbbe1.1	erythroid lineage cell nucleate erythrocyte	standard conditions	Fig. 1 from Murayama et al., 2015
hspa5	whole organism	standard conditions	Fig. 8 from Murayama et al., 2015
ikzf1	(not) thymus lymphoid progenitor cell	standard conditions	Fig. 1 from Murayama et al., 2015
lck	(not) thymus	standard conditions	Fig. 1 from Murayama et al., 2015
lyz	granulocyte	standard conditions	Fig. 1 from Murayama et al., 2015
myb	hematopoietic multipotent progenitor cell (not) hematopoietic stem cell (not) pronephros (not) thymus	standard conditions	Fig. 1, Fig. 8 from Murayama et al., 2015
	hematopoietic stem cell	chemical treatment: 4-phenylbutyric acid	Fig. 8 from Murayama et al., 2015
naca	(not) whole organism posterior side	standard conditions	Fig. 2 from Murayama et al., 2015
npsn	granulocyte	standard conditions	Fig. 1 from Murayama et al., 2015
xbp1	whole organism	standard conditions	Fig. 8 from Murayama et al., 2015

Protein expression No data available

Reporter gene expression No data available

PHENOTYPE
Phenotype in naca^{t30953/t30953}

Phenotype	Conditions	Figures
blood circulation decreased process quality, abnormal	standard conditions	text only from Murayama et al., 2015
caudal vein plexus stromal cell apoptotic, abnormal	control	Fig. 8 from Murayama et al., 2015
definitive hemopoiesis disrupted, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
erythrocyte differentiation decreased process quality, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
erythroid lineage cell hbbe1.1 expression decreased amount, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
eye iridophore disorganized, abnormal	standard conditions	text only from Murayama et al., 2015
granulocyte npsn expression decreased amount, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
granulocyte lyz expression decreased amount, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
granulocyte cebp1 expression decreased amount, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
granulocyte differentiation decreased process quality, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
head decreased size, abnormal	standard conditions	text only from Murayama et al., 2015
hematopoietic multipotent progenitor cell myb expression decreased amount, abnormal	control	Fig. 8 from Murayama et al., 2015
hematopoietic stem cell myb expression absent, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
hematopoietic stem cell absent, abnormal	standard conditions	text only from Murayama et al., 2015
hematopoietic stem cell amount, ameliorated	chemical treatment: 4-phenylbutyric acid	Fig. 8 from Murayama et al., 2015
hematopoietic stem cell myb expression amount, ameliorated	chemical treatment: 4-phenylbutyric acid	Fig. 8 from Murayama et al., 2015
hematopoietic stem cell decreased amount, abnormal	standard conditions	Fig. 1, Fig. 8 from Murayama et al., 2015
hematopoietic system cell death increased occurrence, abnormal	control	Fig. 8 from Murayama et al., 2015
hematopoietic system cell death occurrence, ameliorated	chemical treatment: 4-phenylbutyric acid	Fig. 8 from Murayama et al., 2015
lymphocyte differentiation decreased process quality, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
neutrophil decreased amount, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
neutrophil mislocalised, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
nucleate erythrocyte hbbe1.1 expression decreased amount, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
pericardium edematous, abnormal	standard conditions	text only from Murayama et al., 2015
pronephros myb expression absent, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
thymus myb expression absent, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
thymus lck expression absent, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
thymus lymphoid progenitor cell ikzf1 expression absent, abnormal	standard conditions	Fig. 1 from Murayama et al., 2015
ventral mandibular arch immature, abnormal	standard conditions	text only from Murayama et al., 2015
whole organism dead, abnormal	standard conditions	text only from Murayama et al., 2015
whole organism decreased life span, abnormal	standard conditions	text only from Murayama et al., 2015
whole organism atf4a expression increased amount, abnormal	standard conditions	Fig. 8 from Murayama et al., 2015
whole organism ddit3 expression increased amount, abnormal	standard conditions	Fig. 8 from Murayama et al., 2015
whole organism hspa5 expression increased amount, abnormal	standard conditions	Fig. 8 from Murayama et al., 2015
whole organism xbp1 expression increased amount, abnormal	standard conditions	Fig. 8 from Murayama et al., 2015
whole organism posterior side naca expression absent, abnormal	standard conditions	Fig. 2 from Murayama et al., 2015

CITATIONS (1)